Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
idiopathic pulmonary fibrosis
Pharma
Boehringer breaks IPF treatment drought with new FDA approval
Boehringer's Jascayd is the first new drug to break into the idiopathic pulmonary fibrosis field in more than a decade.
Zoey Becker
Oct 8, 2025 8:56am
United shares surge on Tyvaso win in new lung disease population
Sep 2, 2025 3:34pm
Fierce Biotech
Boehringer 'crossing fingers' ahead of 2 key FDA approvals
Jul 24, 2025 3:00am
Aileron straps in for 2025 with a new name: Rein Therapeutics
Jan 16, 2025 9:05am
Boehringer breathes new life into 'Breathless' campaign
Sep 22, 2022 9:20am
Sandoz launches first US generic of Roche's Esbriet
May 13, 2022 10:15am
Fierce Biotech
Fierce Biotech
Fierce Biotech
Fierce Biotech
